INTRODUCTION
Various populations of regulatory T cells play a central role in the development of peripheral tolerance to allergens and also in successful clinical improvement in allergen-specific immunotherapy which represents the single curative treatment in allergic diseases 1 . T regulatory cells are classified to natural T regulatory cells and induced T regulatory cells. The natural T regulatory cells (nTreg) are self antigen specific CD4 + T cells that express CD25 + in high levels and forkhead box protein (FOX) that are selected in the thymus, and become regulatory T cells in the periphery. The induced-T reg cells (Treg-1) are converted from naïve T cells after encountering specific antigen in the periphery and are characterized by elevated production of interlukin-10 2 . Regulatory T cells inhibit the activation of Thelper cells (Th), mast cells, basophils and eosinophils thus minimizing the production of interlukin-4 (IL-4) and IL-5 which are essential cytokines during the allergic reactions. In addition, Treg also act on B lymphocytes to suppress the production of allergen-specific immunoglobulin-E 3 . Cow milk allergy is believed to be either IgE-mediated in which activation of milk-specific Th cells leads to the production of milk-specific IgE, or non IgE-mediated that may include T cell/mast cell interaction with secretion of inflammatory cytokines including IL-4 and IL-5. Decreased Treg activity has been identified as a factor in both allergy mechanisms 4 . Shreffler and colleagues (2009) 5 showed that children, who were allergic to cow milk and become tolerated, had high percentage of milk-specific CD4 + CD25 + Treg cells in their peripheral blood with high in-vitro proliferation activity when stimulated with cow milk protein. Xystrakis et al. 6 previously reported that culturing of CD4 + T cells isolated from peripheral blood of atopic patients with vitamin D induces the generation of stable IL-10 producing CD4 + CD25 + Treg cells suppressing the proliferation of T helper cells obtained from the same patients. They confirmed the immune regulatory role of vitamin D in atopic patients. However the role of vitamin D in 455 allergy has been controversial and obviously needs a more clarifying research work 7 .
Subjects and methods:
Twenty children with cow's milk allergy from (one month to five years) from the Pediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University. A-Diagnosis of cow milk allergy: 1. Positive skin prick test (SPT) for cow milk (≥3 mm above negative control) using commercial cow's milk allergens extract purchased from allergy pharma. 2. Oral challenge with cow's milk in patients with negative SPT B-Sampling: Four ml of venous blood were drawn from each patient: 2 ml were placed into sterile tube containing K-ethylene diamine tetraacetic acid (K2-EDTA) at a concentration of 1.2 mg/ml for performing PBMCs separation, analysis and culture, and 2 ml was collected into plain vacutainers to be clotted and centrifuged, the yielding serum was kept at -20 until the time of vitamin D analysis.
C-Flow Cytometric Analysis of Separated PBMCs Stained by Monoclonal Antibodies Against CD4, CD25, FOXP3 and IL-10
The separated PBMCs from all patients were subjected to immune-phenotypic analysis by flow cytometry (FCM) co-expression on both Treg and Teff cells was also determined to know the difference between co-expression of both markers on Treg and Teff cells (figure:1). All MoAbs were supplied by eBioscience, USA and stored in refrigerator at 4 o C. For surface staining of CD4 and CD25: Phycoerythrin Texas Red-X (also known as ECD) conjugated anti-CD4 and Phycoerythrin-cyanine 5 (PE-Cy5) conjugated anti-CD25. For intercellular staining of IL-10 and Foxp3: PE conjugated anti-IL-10 and anti-human FOXP 3 staining set: Fluorescein Isothiocyanate (FITC) conjugated anti-FOXP3, Fixation/permeabilization concentrate, Fixation/ permeabilization diluents and permeabilization buffer.
D-In-vitro culture:
Isolated PBMCs from all patients were cultured with milk allergen alone at a dose of 10 ug/ml RPMI (as a stimulator for T cells) in one set and in presence of both vitamin D at a dose of 20 IU/ml RPMI and 10 ug/ml RPMI of milk allergen in another set. After 2 days of culture, MNCs that were collected from both culture sets and were subjected to FCM analysis. E-Statistical Methods: The data were coded, entered and analyzed using Statistical Package for Social Sciences (SPSS) software computer program version "PASW 23.0, IBM Corp., USA, 2015)". Description data were expressed as median & percentiles for quantitative nonparametric measures. Wilcoxon signed rank test for Comparison between two dependant groups for non-parametric data. The probability of error > 0.05was considered non significant (NS), at 0.05 was considered significant (S), while at 0.01 and 0.001 are highly significant (HS).
RESULTS
This study was conducted on 20 well documented allergic infants and children who were diagnosed as having cow milk allergy. They were recruited from outpatient Pediatric Allergy and Immunology Clinic at Children's Hospital, Ain Shams University. They were 9 females and 11 males, their ages ranged from 6 months to 5 years [median (25 percentile; 75percentile): 2 years (9 months; 3.3 years)]. They were divided according to their serum Vitamin D level into : (a) Sufficient vitamin D level: they were 4 (20%) patients their VD level ranged from 31 to 37 ng/ml [median (25 percentile; 75 percentile): 32 ng/ml (31; 36 ng/ml)]. They were all females and their ages ranged from 9 months to 2.5 years [median (25 percentile; 75 percentile): 2 years (1; 2.3 years)]. One (5%) patient had Non-IgE allergy, represented by abdominal distension and constipation and the other 3 patients had IgE allergy; two (10%) patients represented by bronchial asthma (BA) and one (5%) patient represented by urticaria. (b) Insufficient vitamin D level: they were16 patients (80%). their VD level ranged from 10 to 28 ng/ml [median (25 percentile; 75 percentile): 17 ng/ml (11; 22 ng/ml)]. They were 11 males and 5 females and their age ranged from 6 months to 5 years [median (25 percentile; 75 percentile): 2 years (9 months; 3.8 years) (table  1) ]. Eight (40%) patients had IgE allergy; 4 (20%) of them represented by BA and the other 4 (20%) patients represented by urticraia. Five (25%) patients had non-IgE allergy; 3 (15%) patients represented by abdominal distension and constipation, one (5%) patient represented by bloody diarrhea and one (5%) patient complained from failure to thrive. Three (15%) patients had mixed type of allergy represented by atopic dermatitis. 456 In our studied patients, serum level of 25 (OH) VD ranged from 8 to 37 ng/ml. Reference range is shown in (table 2) 16 who hypothesized that the hormone deficiency at a particular time, such as the postnatal period, can increase the susceptibility to colonization by abnormal intestinal microbial flora, that contributes to increased intestinal permeability, which in turn leads to excessive and inappropriate exposure of the immune system to dietary allergens. Probably, VDD could contribute to a non effective tight junction at the skin level which may result in abnormal cutaneous sensitization to food allergens leading to eczema such in cases of atopic dermatitis 17 Moreover, vitamin D also directly suppresses skin inflammation by increasing IL-10 production by cutaneous mast cells
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The present study was in agreement with a cross sectional study done by Allen et al. 19 who found that infants with VD insufficiency were more likely to have food allergies than those with adequate VD level. Another cross sectional study done by Baek et al. 20 found that the degree and prevalence of food allergen sensitization increased in infants with VDD. On the other hand further studies showed no association between VD level and development of food allergy. In a pilot study, Mullins et al. 21 found that the relationship between neonatal 25(OH)D levels and childhood peanut allergy was nonlinear with slightly higher levels (30-39.9 ng/ml) associated with lower risk than those in the reference group. The risk of peanut allergy at the lower levels of neonatal vitamin D, levels present in very few children of this cohort, was not significantly different from the reference group. One retrospective, case control study did not find any association between asthma severity and serum 25(OH) VD concentrations. In this study, 263 subjects with asthma were compared to 284 normal subjects (ages: 2 to 19 years). No significant difference in VD concentrations was found between the asthmatic group and the control group, and the severity of asthma symptoms was not correlated with the vitamin D 458 concentrations 22 . Furthermore, in a birth cohort study, 23 reported no overall association between cord blood vitamin D levels and food-specific IgE. Another study found that cord blood 25(OH)D 3 highest levels were positively associated with the risk of children presenting food allergy in the first 2 years of life. Therefore, the study's message was the demonstration that high vitamin D levels at birth may contribute to a higher risk of food allergy and therefore that no supplementation is required to protect against allergy 24 .
In the meantime, it should consider that all the previous shown evidences and demonstrations could help us to evaluate the opportunity for VD supplementation in children, keeping in mind that there is more evidence for the positive effects of supplementation. It is also very important in this regard to remember Liu et al. For the purpose of this study, PB was collected from our patients and PMNCs were separated and stained with Abs against CD4 CD25 Foxp3 and IL10 to detect the percent of CD4 + CD25 hi Foxp3+ Treg, Treg/ Teff ratio, Foxp3 determination in asthmatic group compared to a healthy control group. Taken together, the evidence is accumulating that differences in Treg activity may be a factor in the development and resolution of food allergies. Importantly, Treg modulates the allergic response by exerting a direct effect on B cells, suppressing the production of allergenspecific IgE and inducing IgG4. Treg also suppress allergic inflammation through direct action on mast cells, basophils and eosinophils
33
The findings from this study were against the findings revealed from a study done by Zhang et al. 34 who carried out their study on 15 asthmatic children; they compared the percentage of T reg cells in the peripheral blood, and in bronchioalveolar lavage fluid (BALF) of asthmatic children with 10 healthy controls .They found a significant decrease in T reg cells in BALF of asthmatic children than the controls while the T reg cells in peripheral blood were equally in both groups. They mentioned that measuring T reg cells at site of inflammation is more accurate than in peripheral blood as normal percentage of T reg in peripheral blood do not exclude its impairment capacity to maintain immune tolerance at diseased site. In the present study, percent of CD4 + CD25 6 showed the same effect of calcitriol on inducing CD4 + IL0 + Treg cells isolated from asthmatic patients in combination with dexamethasone. Unfortunately, VD level in those patients wasn't done. In the present study, it was observed that, better response of VD in induction of Treg occurred in patients with insufficient VD level than in patients with sufficient VD level. This finding may hypothesized that VDRs on T cells and VDREs on Foxp3 gene may have high accessible affinity to VD in status of its deficiency than in its presence in a sufficient state. This observation requires subsequent evaluation. The concentration of 25(OH) D3 used in this study was 20 IU/mL RPMI. This is equal to (80 ng or 200 nmol). Health care professionals need to keep in mind that in general, 100 IU (2.5 mcg) of VD per day can raise the VD blood test only 1 ng/ml or just 2.5 nmol/L after 2 to 3 months
44
Two small trials have addressed the impact of vitamin D supplementation on allergic diseases. A study of 11 children with winter-related atopic dermatitis was enrolled in a pilot study of vitamin D supplementation. The children were randomized to 1000 IU per day of ergocalciferol or placebo for 1 month. There was a trend for improvement of atopic dermatitis scores, but due to the small number and short duration of the trial, the results did not achieve statistical significance
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Another study examined the effect of either inhaled budesonide + 500 IU of cholecalciferol or inhaled budesonide + placebo in asthmatic children for about 6 months. The authors found a reduction in attacks of asthma exacerbations in children who took VD supplementation
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To ensure an adequate intake of vitamin D, the American Academy of Pediatrics has raised the daily recommended intake for children and adolescents, to a dose of 400 IU up to 12 months of age and 400-600 over 12 months, recommending that this supplementation should begin during the first days of life 
